224 related articles for article (PubMed ID: 7448322)
1. Immune deficiency in Hodgkin and non-Hodgkin lymphoma.
El-Haddad SI; El-Ashmawy S; Hassan W; George E; Ali FM; Sharaf MA; Mahfouz M
Biomedicine; 1980 Oct; 32(3):128-33. PubMed ID: 7448322
[TBL] [Abstract][Full Text] [Related]
2. B lymphocytes in untreated patients with malignant lymphoma and Hodgkin's disease.
Gajl-Peczalska KJ; Hansen JA; Bloomfield CD; Good RA
J Clin Invest; 1973 Dec; 52(12):3064-73. PubMed ID: 4201499
[TBL] [Abstract][Full Text] [Related]
3. Delayed cutaneous hypersensitivity and blood lymphocyte count in advanced Hodgkin's and non-Hodgkin's lymphomas.
Gupta S; Seth SK; Udupa KN; Sen PC; Rastogi BL
Ann Chir Gynaecol; 1980; 69(2):79-83. PubMed ID: 7377739
[TBL] [Abstract][Full Text] [Related]
4. Interaction between serum factors and T lymphocytes in Hodgkin's disease. Use as a diagnostic test.
Fuks Z; Strober S; Kaplan HS
N Engl J Med; 1976 Dec; 295(23):1273-8. PubMed ID: 185517
[TBL] [Abstract][Full Text] [Related]
5. Circulating immune complexes and serum lysozyme levels in untreated Hodgkin's disease. Their relationship to immune function.
Spinozzi F; Velardi A; Rambotti P; Losito A; Zampi I; Cernetti C; Gerli R; Martelli MF; Grignani F
J Clin Lab Immunol; 1983 Oct; 12(2):87-92. PubMed ID: 6644793
[TBL] [Abstract][Full Text] [Related]
6. [Cellular immunity in patients with Hodgkin's disease: modification induced by incubating lymphocytes with fetal calf serum and Hodgkin's serum].
Rambotti P; Velardi A; Spinozzi F; Falini B; Martelli MF
Boll Ist Sieroter Milan; 1979 Mar; 58(1):90-9. PubMed ID: 552840
[TBL] [Abstract][Full Text] [Related]
7. Immune deficiency in malignant lymphomas.
Konopka L; Pawelski S; Maślanka K; Zupańska B; Cieśluk S
Chemioterapia; 1987 Jun; 6(2 Suppl):745-8. PubMed ID: 3509538
[No Abstract] [Full Text] [Related]
8. [Phagocytosis measurement in Hodgkin's disease and Non-Hodgkin lymphoma-patients with a new radiometric assay (author's transl)].
Süss J; Balázs C; Bakács T
Allerg Immunol (Leipz); 1982; 28(1):56-63. PubMed ID: 6214175
[TBL] [Abstract][Full Text] [Related]
9. Monocyte function in Hodgkin's disease.
Holm G; Björkholm M; Johansson B; Mellstedt H; Lindemalm C
Clin Exp Immunol; 1982 Jan; 47(1):162-8. PubMed ID: 7094420
[TBL] [Abstract][Full Text] [Related]
10. Studies on the high- and low-affinity rosette-forming T-lymphocytes in patients with Hodgkin's and non-Hodgkin's lymphoma.
Kadhim S; Rees RC; Potter CW; Walker R; Hancock BW
Eur J Cancer (1965); 1981 May; 17(5):569-75. PubMed ID: 6975211
[No Abstract] [Full Text] [Related]
11. [Natural history of the lymphomas].
Mariuzzi GM; Di Loreto C
Minerva Med; 1982 Apr; 73(15):939-44. PubMed ID: 6979007
[No Abstract] [Full Text] [Related]
12. Phytohemagglutinin induced lymphoblastic transformation and rosette forming T lymphocytes: the relationship to prognosis in advanced malignant lymphoma.
Srichaikul T; Chaisiripumkeeree W; Aschararit N; Boonpucknavig S
J Med Assoc Thai; 1979 Jul; 62(7):360-7. PubMed ID: 383870
[No Abstract] [Full Text] [Related]
13. [Persisting deficiency of cell mediated immunity in Hodgkin's disease in complete remission (author's transl)].
Lang JM; Bigel P; Giron C; Faradji A; Oberling F; Mayer S
Nouv Presse Med; 1979 Nov; 8(44):3629-32. PubMed ID: 316521
[TBL] [Abstract][Full Text] [Related]
14. Immune condition in patients with Hodgkin's disease.
Zywicka-Lopaciuk H; Konopka L; Traczyk Z; Pawelski S; Sylwestrowicz T; Maślanka K; Arczyńska-Brojer E; Cieśluk S; Karpowicz M; Małkowska-Zwierz W
Arch Immunol Ther Exp (Warsz); 1980; 28(1):153-60. PubMed ID: 6968189
[TBL] [Abstract][Full Text] [Related]
15. Studies on delayed hypersensitivity of patients with Hodgkin's disease during remission.
Petrov M
Folia Haematol Int Mag Klin Morphol Blutforsch; 1975; 102(1):35-9. PubMed ID: 50967
[TBL] [Abstract][Full Text] [Related]
16. Immunological profile in patients with non-Hodgkin's lymphomas.
Urasiński I; Fiedorowicz-Fabrycy I; Sochacka-Kuzko B; Wichert K
Arch Immunol Ther Exp (Warsz); 1983; 31(4):467-74. PubMed ID: 6689470
[TBL] [Abstract][Full Text] [Related]
17. Reversal of cell surface abnormalities of T lymphocytes in hodgkin's disease after in vitro incubation in fetal sera.
Fuks Z; Strober S; King DP; Kaplan HS
J Immunol; 1976 Oct; 117(4):1331-5. PubMed ID: 1086325
[TBL] [Abstract][Full Text] [Related]
18. Detection of ferritin as a circulating tumor-associated antigen in Hodgkin's disease.
Bieber CP; Bieber MM
Natl Cancer Inst Monogr; 1973 May; 36():147-57. PubMed ID: 4582990
[No Abstract] [Full Text] [Related]
19. Immune status of untreated patients with Hodgkin's disease and prognosis.
Björkholm M; Wedelin C; Holm G; Ogenstad S; Johansson B; Mellstedt H
Cancer Treat Rep; 1982 Apr; 66(4):701-9. PubMed ID: 7074640
[TBL] [Abstract][Full Text] [Related]
20. [Lymphoid depletion type 4 Hodgkin disease. Anatomoclinical review of 35 cases].
Eghbali H; Pétorin C; de Mascarel I; Trojani M; Hoerni-Simon G; Soubeyran P; Hoerni B
Bull Cancer; 1994 Oct; 81(10):866-70. PubMed ID: 7734769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]